Alveron Pharma
PrivateLast Round
Seed
Dec 6, 2024
Total Funding Raised
$17.08M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Alveron Pharma operates in Healthcare & Life Sciences and is based in Oss. Its latest recorded funding round was a Seed round in December 2024.
Alveron Pharma is a biotechnology company developing a unique coagulation platform technology with the world's first cyclodextrin-based anticoagulant reversal drug.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alveron Pharma Comparables
Compare Alveron Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pinwheel Therapeutics | 90% | |
| VarmX | 89% | |
| Bioxodes | 82% |
For institutional investors. Book with your work email.
Alveron Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 6, 2024 | ||||
| Debt | Oct 7, 2021 | ||||
| Series A Extension | Oct 7, 2021 | ||||
| Series A | May 16, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alveron Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Waterman Ventures | Seed, Series A, Series A Extension |
| Thuja Capital | Seed, Series A Extension, Series A |
| Waterman Ventures | Seed, Series A |
| Oost NL | Seed, Series A, Series A Extension |
| East Netherlands Development Agency (Oost NL) | Seed, Series A |
| Broadview Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 33% MoM, reaching 2.2K.
- May 18, 2026
Monthly visitors grew 104% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
Alveron Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alveron Pharma's valuation, stock price, and market status.
Is Alveron Pharma a public or private company?
Alveron Pharma is a private company.
What is the current stock price of Alveron Pharma?
Alveron Pharma is a private company, so its shares have no public market price. Caplight tracks Alveron Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alveron Pharma worth (valuation)?
Valuation information for Alveron Pharma is not publicly available.
Can I buy Alveron Pharma stock?
Alveron Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alveron Pharma's last funding round?
Alveron Pharma's most recent funding round was Seed on December 6, 2024.
Who are the main investors in Alveron Pharma?
Key investors in Alveron Pharma include Thuja Capital, Broadview Ventures.
Will Alveron Pharma IPO soon?
No public IPO plans have been announced for Alveron Pharma.
How can I track Alveron Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Alveron Pharma's shares on secondary markets.